<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1503" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1503/" /><meta name="ncbi_pagename" content="Collagen Type VI-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Collagen Type VI-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Collagen Type VI-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2012/08/09" /><meta name="citation_author" content="Anne Katrin Lampe" /><meta name="citation_author" content="Kevin M Flanigan" /><meta name="citation_author" content="Katharine Mary Bushby" /><meta name="citation_author" content="Debbie Hicks" /><meta name="citation_pmid" content="20301676" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1503/" /><meta name="citation_keywords" content="Bethlem Myopathy" /><meta name="citation_keywords" content="Ullrich Congenital Muscular Dystrophy" /><meta name="citation_keywords" content="Collagen Type VI-Related Autosomal Dominant Limb-Girdle Muscular Dystrophy" /><meta name="citation_keywords" content="Autosomal Recessive Myosclerosis Myopathy" /><meta name="citation_keywords" content="Collagen alpha-1(VI) chain" /><meta name="citation_keywords" content="Collagen alpha-2(VI) chain" /><meta name="citation_keywords" content="Collagen alpha-3(VI) chain" /><meta name="citation_keywords" content="COL6A1" /><meta name="citation_keywords" content="COL6A2" /><meta name="citation_keywords" content="COL6A3" /><meta name="citation_keywords" content="Collagen Type VI-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Collagen Type VI-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Anne Katrin Lampe" /><meta name="DC.Contributor" content="Kevin M Flanigan" /><meta name="DC.Contributor" content="Katharine Mary Bushby" /><meta name="DC.Contributor" content="Debbie Hicks" /><meta name="DC.Date" content="2012/08/09" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1503/" /><meta name="description" content="Collagen type VI-related disorders represent a continuum of overlapping phenotypes with Bethlem myopathy at the mild end, Ullrich congenital muscular dystrophy (CMD) at the severe end, and two rare, less well-defined disorders – autosomal dominant limb-girdle muscular dystrophy and autosomal recessive myosclerosis myopathy – in between. Although Bethlem myopathy and Ullrich CMD were defined long before their molecular basis was known, they remain useful for clarification of prognosis and management." /><meta name="og:title" content="Collagen Type VI-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="Collagen type VI-related disorders represent a continuum of overlapping phenotypes with Bethlem myopathy at the mild end, Ullrich congenital muscular dystrophy (CMD) at the severe end, and two rare, less well-defined disorders – autosomal dominant limb-girdle muscular dystrophy and autosomal recessive myosclerosis myopathy – in between. Although Bethlem myopathy and Ullrich CMD were defined long before their molecular basis was known, they remain useful for clarification of prognosis and management." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1503/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/bethlem/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1503/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89E4B3DFC836810000000004EA026C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1503_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1503_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ciss/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pai-1-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1503_"><span class="title" itemprop="name">Collagen Type VI-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Anne Katrin Lampe</span>, MD, <span itemprop="author">Kevin M Flanigan</span>, MD, <span itemprop="author">Katharine Mary Bushby</span>, MD, MBCHB FRCP, and <span itemprop="author">Debbie Hicks</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1503_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1503_ai__"><div class="contrib half_rhythm"><span itemprop="author">Anne Katrin Lampe</span>, MD<div class="affiliation small">South East of Scotland Clinical Genetic Service<br />Western General Hospital<br />Edinburgh, Scotland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.shn.tocs.thul@epmal.enna" class="oemail">ku.shn.tocs.thul@epmal.enna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kevin M Flanigan</span>, MD<div class="affiliation small">The Research Institute at Nationwide Children's Hospital<br />Columbus, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcediwnoitan@naginalf.nivek" class="oemail">gro.snerdlihcediwnoitan@naginalf.nivek</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Katharine Mary Bushby</span>, MD, MBCHB FRCP<div class="affiliation small">Institute of Genetic Medicine<br />University of Newcastle upon Tyne<br />Newcastle upon Tyne, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcn@ybhsub.etak" class="oemail">ku.ca.lcn@ybhsub.etak</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Debbie Hicks</span>, PhD<div class="affiliation small">Institute of Genetic Medicine<br />University of Newcastle upon Tyne<br />Newcastle upon Tyne, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcn@skcih.eibbed" class="oemail">ku.ca.lcn@skcih.eibbed</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 25, 2004</span>; Last Update: <span itemprop="dateModified">August 9, 2012</span>.</p><p><em>Estimated reading time: 26 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="bethlem.Summary" itemprop="description"><h2 id="_bethlem_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Collagen type VI-related disorders represent a continuum of overlapping phenotypes with Bethlem myopathy at the mild end, Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (CMD) at the severe end, and two rare, less well-defined disorders &#x02013; <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> limb-girdle muscular dystrophy and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myosclerosis myopathy &#x02013; in between. Although Bethlem myopathy and Ullrich CMD were defined long before their molecular basis was known, they remain useful for clarification of prognosis and management.</p><p>Bethlem myopathy, characterized by the combination of proximal muscle weakness and variable contractures, affects most frequently the long finger flexors, elbows, and ankles. Onset may be prenatal (characterized by decreased fetal movements), neonatal (hypotonia or torticollis), in early childhood (delayed motor milestones, muscle weakness, and contractures), or in adulthood (proximal weakness and Achilles tendon or long finger flexor contractures). Because of slow progression, more than two thirds of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals over age 50 years rely on supportive means for outdoor mobility. Respiratory involvement is rare and appears to be related to more severe muscle weakness in later life.</p><p>Ullrich CMD is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> weakness and hypotonia, proximal joint contractures, and striking hyperlaxity of distal joints. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children acquire the ability to walk independently; however, progression of the disease often results in later loss of ambulation. Early and severe respiratory involvement may require ventilatory support in the first or second decade of life.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis depends on typical clinical features; normal or only mildly elevated serum creatine kinase concentration; suggestive pattern on muscle magnetic resonance imaging (MRI); muscle biopsy with collagen VI immunolabeling (for suspected Ullrich CMD) or skin biopsy and dermal fibroblast culture with collagen VI immunolabeling (for suspected Bethlem myopathy); and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>COL6A1</i>, <i>COL6A2</i>, and <i>COL6A3</i>, the three genes encoding the three collagen VI peptide chains.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> As needed based on clinical findings: physiotherapy regarding stretching exercises, splinting, and mobility aids; orthopedic assessment if surgery for Achilles tendon contractures is being considered; therapy for scoliosis. Respiratory: evaluation for nocturnal hypoventilation; prophylaxis of chest infections with vaccination and physiotherapy; aggressive treatment of pulmonary infections. Nutrition: assessment of nutritional status and growth; management of feeding difficulties.</p><p><i>Surveillance</i>: Routine assessment of: muscle weakness, scoliosis, joint contractures, and mobility; respiratory function; and nutritional status.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>The Bethlem myopathy <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is usually inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner and the UMD phenotype is usually inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner; however, exceptions occur. In the few cases reported to date, it appears that autosomal dominant limb-girdle muscular dystrophy is inherited in an autosomal dominant manner and the myosclerosis myopathy phenotype is inherited in an autosomal recessive manner. Carrier testing for autosomal recessive collagen VI-related disorders and prenatal testing are possible if the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="bethlem.GeneReview_Scope"><h2 id="_bethlem_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="bethlem.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1503/table/bethlem.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bethlem.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bethlem.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Collagen Type VI-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_bethlem.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Bethlem myopathy</div></li><li class="half_rhythm"><div>Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy</div></li><li class="half_rhythm"><div>Collagen type VI-related <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> limb-girdle muscular dystrophy</div></li><li class="half_rhythm"><div>Autosomal recessive myosclerosis myopathy</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#bethlem.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="bethlem.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#bethlem.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="bethlem.Diagnosis"><h2 id="_bethlem_Diagnosis_">Diagnosis</h2><p>The collagen type VI-related disorders, caused by mutation of <i>COL6A1</i>, <i>COL6A2</i>, or <i>COL6A3</i>, represent a clinical spectrum including Bethlem myopathy at the mild end, Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (CMD) at the severe end, and two less well-defined disorders &#x02013; <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> limb-girdle muscular dystrophy and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myosclerosis myopathy &#x02013; in between.</p><p>Note: Although these phenotypes are now recognized to comprise a continuum of overlapping phenotypes, the clinical designations are useful for clarification of prognosis and management.</p><p><b>Clinical findings</b></p><p>Bethlem myopathy is recognized clinically by the combination of the following [<a class="bk_pop" href="#bethlem.REF.j_bsis.1999.649">J&#x000f6;bsis et al 1999</a>]:</p><ul><li class="half_rhythm"><div>Proximal muscle weakness</div></li><li class="half_rhythm"><div>Variable contractures, affecting most frequently the long finger flexors, elbows, and ankles</div></li></ul><p>Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (CMD) is recognized clinically by the combination of the following [<a class="bk_pop" href="#bethlem.REF.voit.1998.65">Voit 1998</a>, <a class="bk_pop" href="#bethlem.REF.muntoni.2002.889">Muntoni et al 2002</a>]:</p><ul><li class="half_rhythm"><div>Congenital weakness and hypotonia</div></li><li class="half_rhythm"><div>Proximal joint contractures</div></li><li class="half_rhythm"><div>Striking hyperlaxity of distal joints</div></li></ul><p>Note: As Bethlem myopathy may also present at birth, it may be difficult to categorize a neonate who has no family history of muscle disease into either Bethlem myopathy or Ullrich CMD initially; however, with time the stable acquisition of ambulation allows the diagnosis of Bethlem myopathy.</p><p>In both Bethlem myopathy and Ullrich CMD:</p><ul><li class="half_rhythm"><div>Intelligence is normal (in contrast to some other CMD subtypes).</div></li><li class="half_rhythm"><div>Unusual skin features may be present, including follicular hyperkeratosis, and keloid or "cigarette-paper" scarring [<a class="bk_pop" href="#bethlem.REF.pepe.2002.984">Pepe et al 2002</a>].</div></li><li class="half_rhythm"><div>Serum creatine kinase concentration is normal or mildly elevated.</div></li></ul><p><b>Muscle MRI.</b> Bethlem myopathy and Ullrich CMD have distinct patterns of muscle involvement, although some overlap exists [<a class="bk_pop" href="#bethlem.REF.mercuri.2005.303">Mercuri et al 2005</a>].</p><ul><li class="half_rhythm"><div>In thigh muscles:</div><ul><li class="half_rhythm"><div>In Bethlem myopathy the vasti muscles appear to be the most frequently and strikingly affected, with a rim of abnormal signal at the periphery of each muscle and relative sparing of the central part. A peculiar involvement of the rectus femoris with a central area of abnormal signal within the muscle is also a frequent finding. See <a class="figpopup" href="/books/NBK1503/figure/bethlem.F1/?report=objectonly" target="object" rid-figpopup="figbethlemF1" rid-ob="figobbethlemF1">Figure 1</a>.</div></li><li class="half_rhythm"><div>In Ullrich CMD more diffuse involvement is observed with relative sparing of the sartorius, gracilis, and adductor longus. See <a class="figpopup" href="/books/NBK1503/figure/bethlem.F2/?report=objectonly" target="object" rid-figpopup="figbethlemF2" rid-ob="figobbethlemF2">Figure 2</a>.</div></li></ul></li><li class="half_rhythm"><div>In calf muscles: Bethlem myopathy and Ullrich CMD often show a rim of abnormal signal at the periphery of soleus and gastrocnemii.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figbethlemF1" co-legend-rid="figlgndbethlemF1"><a href="/books/NBK1503/figure/bethlem.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figbethlemF1" rid-ob="figobbethlemF1"><img class="small-thumb" src="/books/NBK1503/bin/bethlem-Image001.gif" src-large="/books/NBK1503/bin/bethlem-Image001.jpg" alt="Figure 1. . Transverse T1-weighted images through thigh muscles in four individuals with Bethlem myopathy (a-d)." /></a><div class="icnblk_cntnt" id="figlgndbethlemF1"><h4 id="bethlem.F1"><a href="/books/NBK1503/figure/bethlem.F1/?report=objectonly" target="object" rid-ob="figobbethlemF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Transverse T<sub>1</sub>-weighted images through thigh muscles in four individuals with Bethlem myopathy (a-d). Note the relative sparing of the central part of the vastus lateralis with a rim of increased signal at the periphery of the muscle and the prominent <a href="/books/NBK1503/figure/bethlem.F1/?report=objectonly" target="object" rid-ob="figobbethlemF1">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figbethlemF2" co-legend-rid="figlgndbethlemF2"><a href="/books/NBK1503/figure/bethlem.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figbethlemF2" rid-ob="figobbethlemF2"><img class="small-thumb" src="/books/NBK1503/bin/bethlem-Image002.gif" src-large="/books/NBK1503/bin/bethlem-Image002.jpg" alt="Figure 2. . Transverse T1-weighted images through thigh muscles in four individuals with Ullrich CMD." /></a><div class="icnblk_cntnt" id="figlgndbethlemF2"><h4 id="bethlem.F2"><a href="/books/NBK1503/figure/bethlem.F2/?report=objectonly" target="object" rid-ob="figobbethlemF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Transverse T<sub>1</sub>-weighted images through thigh muscles in four individuals with Ullrich CMD. Note the diffuse involvement of the thigh with relative sparing of sartorius, gracilis, and rectus femoris (arrows) in three young affected individuals (a-c). A <a href="/books/NBK1503/figure/bethlem.F2/?report=objectonly" target="object" rid-ob="figobbethlemF2">(more...)</a></p></div></div><p><b>Tissue studies</b></p><p>Bethlem myopathy</p><ul><li class="half_rhythm"><div>Muscle biopsy reveals myopathic or dystrophic changes. Collagen VI immunolabeling is often normal or shows only subtle alterations.</div></li><li class="half_rhythm"><div>Immunofluorescent analysis of collagen VI in dermal fibroblast cultures is predictive of Bethlem myopathy [<a class="bk_pop" href="#bethlem.REF.hicks.2008.1192">Hicks et al 2008</a>]. See <a class="figpopup" href="/books/NBK1503/figure/bethlem.F3/?report=objectonly" target="object" rid-figpopup="figbethlemF3" rid-ob="figobbethlemF3">Figure 3</a>.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figbethlemF3" co-legend-rid="figlgndbethlemF3"><a href="/books/NBK1503/figure/bethlem.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figbethlemF3" rid-ob="figobbethlemF3"><img class="small-thumb" src="/books/NBK1503/bin/bethlem-Image003.gif" src-large="/books/NBK1503/bin/bethlem-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndbethlemF3"><h4 id="bethlem.F3"><a href="/books/NBK1503/figure/bethlem.F3/?report=objectonly" target="object" rid-ob="figobbethlemF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Dermal fibroblasts in Bethlem myopathy A. Normal control with collagen VI labeling with antibody</p></div></div><p>Ullrich CMD</p><ul><li class="half_rhythm"><div>Muscle biopsy more commonly shows dystrophic features with degeneration and regeneration and replacement of muscle with fat and fibrous connective tissue. Collagen VI immunolabeling from the endomysium and basal lamina ranges from absent to moderately or markedly reduced, but may be normal around capillaries [<a class="bk_pop" href="#bethlem.REF.higuchi.2003.310">Higuchi et al 2003</a>].</div></li><li class="half_rhythm"><div>Loss of collagen VI in dermal fibroblast cultures may be a useful adjunct to the diagnosis [<a class="bk_pop" href="#bethlem.REF.jimenezmallebrera.2006.571">Jimenez-Mallebrera et al 2006</a>]. See <a class="figpopup" href="/books/NBK1503/figure/bethlem.F3/?report=objectonly" target="object" rid-figpopup="figbethlemF3" rid-ob="figobbethlemF3">Figure 3</a>.</div></li></ul><div id="bethlem.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Genes.</b>
<i>COL6A1</i>, <i>COL6A2</i>, and <i>COL6A3</i> are the three genes in which pathogenic variants are known to cause collagen type VI-related disorders.</p><div id="bethlem.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Collagen VI-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1503/table/bethlem.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bethlem.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Proportion of Collagen VI-Related Disorders Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th><th id="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL6A1</i></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">38%</td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Duplication/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions&#x000a0;<sup>6,&#x000a0;7,&#x000a0;8</sup></td></tr><tr><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL6A2</i></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">44%</td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Duplication/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions&#x000a0;<sup>7,&#x000a0;8,&#x000a0;9</sup></td></tr><tr><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL6A3</i></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">18%</td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Duplication/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_bethlem.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown; none reported&#x000a0;<sup>10</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bethlem.TF.1.1"><p class="no_margin">See <a href="/books/NBK1503/#bethlem.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="bethlem.TF.1.2"><p class="no_margin">Author, personal observation</p></div></dd><dt>3. </dt><dd><div id="bethlem.TF.1.3"><p class="no_margin">See <a href="#bethlem.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>4. </dt><dd><div id="bethlem.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="bethlem.TF.1.5"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA; included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>6. </dt><dd><div id="bethlem.TF.1.6"><p class="no_margin">Highly similar <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> deletions were identified in a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>-prone region of <i>COL6A1</i> in two individuals, one with a BM and one with an Ullrich CMD <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#bethlem.REF.pepe.2006.190">Pepe et al 2006</a>].</p></div></dd><dt>7. </dt><dd><div id="bethlem.TF.1.7"><p class="no_margin">A novel type of <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> underlying recessively inherited UCMD was reported in two families with Ullrich CMD with large <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> deletions of <i>COL6A1</i> and <i>COL6A2</i> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 21 [<a class="bk_pop" href="#bethlem.REF.foley.2011.206">Foley et al 2011</a>].</p></div></dd><dt>8. </dt><dd><div id="bethlem.TF.1.8"><p class="no_margin">Large or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions appear to be rare in collagen VI-related disorders.</p></div></dd><dt>9. </dt><dd><div id="bethlem.TF.1.9"><p class="no_margin">In addition to the finding described in footnote 5, a deep <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in <i>COL6A2</i> (identified by array CGH) was one of two <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in an individual with a BM <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#bethlem.REF.bovolenta.2010.44">Bovolenta et al 2010</a>].</p></div></dd><dt>10. </dt><dd><div id="bethlem.TF.1.10"><p class="no_margin">No deletions or duplications involving <i>COL6A3</i> have been reported to cause collagen type VI-related disorders.</p></div></dd></dl></div></div></div></div><div id="bethlem.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">Clinical evaluation</div></li><li class="half_rhythm"><div class="half_rhythm">Measurement of serum creatine kinase concentration</div></li><li class="half_rhythm"><div class="half_rhythm">Muscle MRI for Bethlem myopathy</div><div class="half_rhythm">Note: Muscle MRI is not always done in Ullrich CMD because of the difficulty associated with sedating babies and small children.</div></li><li class="half_rhythm"><div class="half_rhythm">Tissue evaluation</div><ul><li class="half_rhythm"><div>For suspected Ullrich CMD: muscle biopsy with collagen VI immunolabeling</div></li><li class="half_rhythm"><div>For suspected Bethlem myopathy: skin biopsy and dermal fibroblast culture with collagen VI immunolabeling</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Molecular genetic testing of <i>COL6A1</i>, <i>COL6A2</i>, <i>COL6A3</i></div><div class="half_rhythm">Using <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA derived from peripheral blood samples, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the three genes encoding collagen VI detected putative pathogenic variants in [<a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>] (see Note):</div><ul><li class="half_rhythm"><div>66% of individuals clinically classified as having Bethlem myopathy</div></li><li class="half_rhythm"><div>56% of individuals with Bethlem myopathy with an unusually severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li><li class="half_rhythm"><div>79% of individuals with Ullrich CMD</div></li></ul></li></ul><p>Note: (1) The low variant detection rate is largely attributable to the high degree of genetic heterogeneity in Bethlem myopathy and Ullrich CMD, rather than failure to detect <i>COL6A</i> pathogenic variants; however, deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> and cryptic variants are not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis does not increase the variant detection frequency greatly, if at all. (2) The recent finding of <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> forms of collagen type VI-related disorders emphasizes the importance of sequencing the entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of the three genes (<i>COL6A1</i>, <i>COL6A2</i>, <i>COL6A3</i>) to ensure detection of two mutant alleles, when present [<a class="bk_pop" href="#bethlem.REF.gualandi.2009.1883">Gualandi et al 2009</a>].</p><p><b>Carrier testing for relatives</b>
<b>at risk for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> forms of collagen VI-related disorders</b> requires prior identification of the pathogenic variants in the family.</p><p>Note: Carriers (heterozygotes) for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> forms of collagen type VI-related disorders are not at risk of developing the disorder.</p><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the pathogenic variants in the family.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p></div></div><div id="bethlem.Clinical_Characteristics"><h2 id="_bethlem_Clinical_Characteristics_">Clinical Characteristics</h2><div id="bethlem.Clinical_Description"><h3>Clinical Description</h3><p>The phenotypes associated with collagen type VI-related disorders, once thought to be distinct entities, were clinically defined long before their molecular basis was discovered. The collagen type VI-related disorders are now recognized to comprise a continuum of overlapping phenotypes with Bethlem myopathy at the mild end, Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (CMD) at the severe end, and two less well-defined disorders &#x02013; <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> limb-girdle muscular dystrophy and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myosclerosis myopathy &#x02013; in between. Although these phenotypes are now recognized to overlap and fall on a continuum, these clinical designations are useful for clarification of prognosis and management.</p><div id="bethlem.Bethlem_Myopathy"><h4>Bethlem Myopathy</h4><p>The onset of Bethlem myopathy ranges from prenatal to mid-adulthood. Prenatal onset is characterized by decreased fetal movements; neonatal onset with hypotonia or torticollis; early-childhood onset with delayed motor milestones, muscle weakness, and contractures; and adult onset (4th-6th decade) with proximal weakness and Achilles tendon or long finger flexor contractures. As some adults are unaware of weakness, age of onset cannot always be established.</p><p>The contractures may come and go during childhood, but nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals eventually exhibit flexion contractures of the fingers, wrists, elbows, and ankles. These contractures can become disabling when combined with muscle weakness.</p><p>Individuals can have moderate weakness and atrophy of the muscles of the trunk and limbs with proximal muscles being more involved than distal muscles and extensors more than flexors.</p><p>As a result of slow but ongoing progression of the condition, more than two thirds of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals over age 50 years need supportive means (i.e., canes, crutches, or wheelchair) for outdoor mobility [<a class="bk_pop" href="#bethlem.REF.j_bsis.1999.649">J&#x000f6;bsis et al 1999</a>, <a class="bk_pop" href="#bethlem.REF.pepe.1999b.802">Pepe et al 1999b</a>].</p><p>Respiratory muscle and especially diaphragmatic involvement necessitating artificial nocturnal respiratory support is part of the clinical spectrum but is rare and appears to be related to severe weakness occurring in later life [<a class="bk_pop" href="#bethlem.REF.haq.1999.174">Haq et al 1999</a>]. Respiratory failure may supervene prior to loss of ambulation and may be associated with diaphragmatic weakness [<a class="bk_pop" href="#bethlem.REF.haq.1999.174">Haq et al 1999</a>].</p><p>Cardiac function is usually normal [<a class="bk_pop" href="#bethlem.REF.mohire.1988.573">Mohire et al 1988</a>, <a class="bk_pop" href="#bethlem.REF.de_visser.1992.591">de Visser et al 1992</a>].</p></div><div id="bethlem.Ullrich_Congenital_Muscular_Dyst"><h4>Ullrich Congenital Muscular Dystrophy (CMD)</h4><p>In addition to characteristic muscle weakness of early onset, proximal joint contractures, and hyperelasticity of the wrists and ankles, other features observed are <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hip dislocation, prominent calcanei, and a transient kyphotic deformity at birth.</p><p>With time, the distal hyperlaxity can evolve into marked finger flexion contractures and tight Achilles tendons [<a class="bk_pop" href="#bethlem.REF.furukawa.1977.426">Furukawa &#x00026; Toyokura 1977</a>, <a class="bk_pop" href="#bethlem.REF.muntoni.2002.889">Muntoni et al 2002</a>].</p><p>Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children acquire the ability to walk independently; however, progression of the disease often results in later loss of ambulation.</p><p>Rigidity of the spine is often associated with scoliosis.</p><p>Early and severe respiratory involvement may require artificial ventilatory support in the first or second decade of life.</p><p>Failure to thrive is common.</p><p>Follicular hyperkeratosis over the extensor surfaces of upper and lower limbs and keloid and cigarette paper scar formation are common.</p><p>Cardiac involvement has not been documented to date.</p></div><div id="bethlem.Other_Phenotypes"><h4>Other Phenotypes</h4><p>The two additional conditions included in the spectrum of collagen VI myopathies are:</p><ul><li class="half_rhythm"><div>Autosomal dominant limb-girdle muscular dystrophy caused by pathogenic variants in <i>COL6A1/COL6A2</i> in three families and <i>COL6A3</i> in one family [<a class="bk_pop" href="#bethlem.REF.scacheri.2002.593">Scacheri et al 2002</a>]. Although some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had mild weakness with only limited functional impairment, others had a more severe, dystrophic-like weakness with findings including Gower&#x02019;s maneuver, toe walking, and loss of ambulation. Joint contractures were either absent or much milder than those of typical Bethlem myopathy. Whereas findings of Bethlem myopathy are typically present in infancy, the age at onset in these three families ranged from infancy, to early childhood, to adulthood.</div></li><li class="half_rhythm"><div>Autosomal recessive myosclerosis myopathy caused by mutation of <i>COL6A2</i> in two individuals from one family [<a class="bk_pop" href="#bethlem.REF.merlini.2008.1245">Merlini et al 2008</a>]. Myosclerosis myopathy is characterized by difficulty in walking in early childhood, toe walking, and progressive contractures of calf muscles. In the early 30s the muscles are slender with a firm "woody" consistency and associated with contractures that restrict range of motion of many joints.</div></li></ul></div></div><div id="bethlem.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>In 42 individuals with collagen VI-related myopathy with onset before age two years, <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants that caused premature termination codons (associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance) were associated with the most severe phenotypes (ambulation never achieved), whereas <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> skipping and glycine <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance) were associated with the moderate-progressive phenotypes (loss of ambulation) [<a class="bk_pop" href="#bethlem.REF.bri_as.2010.511">Bri&#x000f1;as et al 2010</a>].</p><p>In <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (CMD), a large number of pathogenic variants appear to result in premature termination codons with consequent <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> decay. Premature termination codons occur by nonsense variants [<a class="bk_pop" href="#bethlem.REF.demir.2002.1446">Demir et al 2002</a>, <a class="bk_pop" href="#bethlem.REF.giusti.2005.400">Giusti et al 2005</a>, <a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>] or frameshift-inducing deletions [<a class="bk_pop" href="#bethlem.REF.higuchi.2001.261">Higuchi et al 2001</a>, <a class="bk_pop" href="#bethlem.REF.giusti.2005.400">Giusti et al 2005</a>, <a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>], insertions [<a class="bk_pop" href="#bethlem.REF.camacho_vanegas.2001.7516">Camacho Vanegas et al 2001</a>], duplications [<a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>], and splice changes [<a class="bk_pop" href="#bethlem.REF.camacho_vanegas.2001.7516">Camacho Vanegas et al 2001</a>, <a class="bk_pop" href="#bethlem.REF.ishikawa.2002.920">Ishikawa et al 2002</a>]. Splice variants leading to <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions as well as in-frame deletions are other common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> types in Ullrich CMD [<a class="bk_pop" href="#bethlem.REF.demir.2002.1446">Demir et al 2002</a>, <a class="bk_pop" href="#bethlem.REF.ishikawa.2004.620">Ishikawa et al 2004</a>, <a class="bk_pop" href="#bethlem.REF.baker.2005.279">Baker et al 2005</a>, <a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>].</p><p>Bethlem myopathy and Ullrich CMD represent a clinical continuum in which individuals presenting with intermediate phenotypes could be considered to have either "mild Ullrich CMD" or "severe Bethlem myopathy." In this context, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> single amino acid substitutions disrupting the Gly-Xaa-Yaa motif of the highly conserved triple helical <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> have been described in a milder form of Ullrich CMD [<a class="bk_pop" href="#bethlem.REF.giusti.2005.400">Giusti et al 2005</a>, <a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>]. As for Bethlem myopathy, given the high number of variants resulting in benign amino acid changes described for the genes encoding collagen VI subunits, it is difficult to be certain about the pathogenicity of <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants other than glycine substitutions within the triple helical domain.</p><p>In <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> Ullrich CMD, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants leading to <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions and heterozygous in-frame deletions in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> share a common motif: they preserve a unique cysteine important for dimer formation, allowing secretion of abnormal tetramers with a consequent <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect on microfibrillar assembly [<a class="bk_pop" href="#bethlem.REF.pan.2003.355">Pan et al 2003</a>, <a class="bk_pop" href="#bethlem.REF.baker.2005.279">Baker et al 2005</a>].</p></div><div id="bethlem.Penetrance"><h3>Penetrance</h3><p>Parents of individuals with recessively inherited collagen VI-related disorders are usually <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>COL6A1</i>, <i>COL6A2</i>, or <i>COL6A3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, but do not appear to manifest any related symptoms.</p><p>Individuals with dominantly inherited collagen VI-related disorders are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>COL6A1</i>, <i>COL6A2</i>, or <i>COL6A3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and are symptomatic. However, careful clinical examination may be necessary to identify findings diagnostic of a collagen type VI-related disorder in their minimally symptomatic parents [<a class="bk_pop" href="#bethlem.REF.peat.2007.547">Peat et al 2007</a>].</p></div><div id="bethlem.Anticipation"><h3>Anticipation</h3><p>Anticipation is not observed.</p></div><div id="bethlem.Nomenclature"><h3>Nomenclature</h3><p><b>Bethlem myopathy</b> was first described as "benign myopathy with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance" [<a class="bk_pop" href="#bethlem.REF.bethlem.1976.91">Bethlem &#x00026; Wijngaarden 1976</a>]. Other terms in use:</p><ul><li class="half_rhythm"><div>Benign <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathy</div></li><li class="half_rhythm"><div>Benign <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy</div></li><li class="half_rhythm"><div>Benign <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathy with contractures</div></li></ul><p><b>Ullrich CMD</b> was first described as "<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> atonic sclerotic muscular dystrophy" [<a class="bk_pop" href="#bethlem.REF.ullrich.1930.171">Ullrich 1930</a>]. Other terms used in the past:</p><ul><li class="half_rhythm"><div>Congenital hypotonic sclerotic muscular dystrophy</div></li><li class="half_rhythm"><div>Congenital muscular dystrophy with distal laxity</div></li></ul></div><div id="bethlem.Prevalence"><h3>Prevalence</h3><p>Prevalence is estimated at 0.77:100,000 in Bethlem myopathy and 0.13:100,000 in Ullrich CMD [<a class="bk_pop" href="#bethlem.REF.norwood.2009.3175">Norwood et al 2009</a>]; the disorders are probably currently underdiagnosed.</p><p>Both conditions have been described in individuals from a variety of ethnic backgrounds.</p></div></div><div id="bethlem.Genetically_Related_Allelic_Diso"><h2 id="_bethlem_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> have been associated with mutation of <i>COL6A1</i>, <i>COL6A2</i>, or <i>COL6A3.</i></p></div><div id="bethlem.Differential_Diagnosis"><h2 id="_bethlem_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of the two major phenotypes observed in the collagen VI-related disorders is discussed below. Of note, a normal to mildly elevated CK, suggestive findings on muscle MRI, and the lack of a cardiac <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> generally distinguish the collagen type VI-related disorders from these other disorders.</p><p><b>Bethlem myopathy.</b> When contractures are subtle or missed, the major differential diagnoses are the limb-girdle muscular dystrophies (LGMDs) [<a class="bk_pop" href="#bethlem.REF.scacheri.2002.593">Scacheri et al 2002</a>].</p><p>When contractures are a prominent feature, the major differential diagnoses are <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a href="/books/n/gene/edmd/">Emery-Dreifuss muscular dystrophy</a>, both of which are associated with serious cardiac complications [<a class="bk_pop" href="#bethlem.REF.pepe.2002.984">Pepe et al 2002</a>].</p><p>Immunohistochemical testing (i.e., western blotting and immunohistochemistry) performed on muscle biopsy and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can help to establish the diagnosis of some LGMD subtypes such as sarcoglycanopathy, <a href="/books/n/gene/lgmd2a/">calpainopathy</a>, and <a href="/books/n/gene/miyoshi/">dysferlinopathy</a> as well as <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a href="/books/n/gene/edmd/">Emery-Dreifuss muscular dystrophy</a>.</p><p><b>Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (CMD).</b> In the neonatal period, the differential diagnosis includes the following:</p><ul><li class="half_rhythm"><div>Other forms of CMD. These do not generally present with the distal hyperlaxity characteristic of Ullrich CMD and are usually associated with serum creatine kinase concentrations higher than those observed in Ullrich CMD. Biochemical testing (i.e., western blotting and immunohistochemistry) performed on the muscle biopsy and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can help to establish the diagnosis of some CMD subtypes such as <a href="/books/n/gene/mdef-cmd/"><i>LAMA2</i>-related muscular dystrophies</a> (MDC1A) or MDC1C (caused by pathogenic variants in <i>FKRP</i>). In addition, brain MRI may show white matter changes in some CMD subtypes (e.g., <i>LAMA2</i>-related muscular dystrophies) and structural abnormalities in others (e.g., Walker-Warburg syndrome, muscle-eye-brain disease, and <a href="/books/n/gene/fcmd/">Fukuyama congenital muscular dystrophy</a> [FCMD]).</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sma/">Spinal muscular atrophy</a> (SMA). SMA shows features of denervation rather than myopathic or dystrophic changes on muscle biopsy. It can usually be diagnosed by demonstrating pathogenic variants in <i>SMN</i>1 or <i>SMN2</i>.</div></li><li class="half_rhythm"><div>Forms of <a href="/books/n/gene/eds/">Ehlers-Danlos syndrome, classic type</a> or <a href="/books/n/gene/marfan/">Marfan syndrome</a>. Neither of these disorders is typically associated with significant muscle weakness or an abnormal muscle biopsy, but they may be confused with Ullrich CMD because of joint laxity.</div></li><li class="half_rhythm"><div>Rigid spine syndromes. A proportion of rigid spine syndromes are caused by pathogenic variants in <i>SELENON</i> (<i>SEPN1</i>) (OMIM <a href="https://omim.org/entry/606210" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606210</a>), which may overlap with Ullrich CMD later as the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> develops.</div></li></ul></div><div id="bethlem.Management"><h2 id="_bethlem_Management_">Management</h2><div id="bethlem.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p><b>Bethlem myopathy.</b> To establish the extent of disease and needs of an individual diagnosed with Bethlem myopathy, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Evaluation of degree of muscle weakness and mobility</div></li><li class="half_rhythm"><div>Joint examination for contractures</div></li><li class="half_rhythm"><div>Physiotherapy assessment and advice regarding stretches/splints for contractures and mobility aids</div></li><li class="half_rhythm"><div>Possibly orthopedic evaluation if surgery is to be considered for tendon Achilles contractures</div></li><li class="half_rhythm"><div>Assessment of respiratory status</div><ul><li class="half_rhythm"><div>Seek history of clinical symptoms of nocturnal hypoventilation such as early morning nausea and headaches, daytime somnolence.</div></li><li class="half_rhythm"><div>Inquire about frequency and severity of chest infections; if any concerns, perform spirometry and nocturnal pulse oximetry.</div></li></ul></li></ul><p><b>Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (CMD).</b> To establish the extent of disease and needs of an individual diagnosed with Ullrich CMD, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Evaluation of degree of muscle weakness and mobility</div></li><li class="half_rhythm"><div>Examination of back for scoliosis</div></li><li class="half_rhythm"><div>Joint examination for contractures and hyperlaxity</div></li><li class="half_rhythm"><div>Physiotherapy assessment and advice regarding stretches/splints for contractures and mobility aids such as swivel walkers and standing frames to achieve upright posture and protect against the development of scoliosis and other contractures</div></li><li class="half_rhythm"><div>Possibly x-rays of thoracolumbar spine and orthopedic evaluation if scoliosis is clinically suspected</div></li><li class="half_rhythm"><div>Possibly orthopedic evaluation if hip dislocation is suspected or surgery is to be considered for tendon Achilles contractures</div></li><li class="half_rhythm"><div>Assessment of respiratory status</div><ul><li class="half_rhythm"><div>Seek history of clinical symptoms of nocturnal hypoventilation such as early morning nausea and headaches, daytime somnolence.</div></li><li class="half_rhythm"><div>Inquire about frequency and severity of chest infections; if any concerns, perform spirometry and nocturnal pulse oximetry.</div></li></ul></li><li class="half_rhythm"><div>Assessment of growth and feeding. Feeding difficulties may manifest as failure to thrive or excessive time taken to finish eating a meal.</div></li></ul></div><div id="bethlem.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Bethlem myopathy</b></p><ul><li class="half_rhythm"><div>Physiotherapy and possibly orthopedic management of contractures are useful to maintain mobility. Contractures may be dynamic and may require stretching and splinting.</div></li><li class="half_rhythm"><div>Symptoms of nocturnal hypoventilation respond well to noninvasive respiratory support such as mask ventilation [<a class="bk_pop" href="#bethlem.REF.wallgrenpettersson.2004.56">Wallgren-Pettersson et al 2004</a>].</div></li><li class="half_rhythm"><div>Approximately two thirds of individuals over age 50 years need supportive aids for outdoor mobility [<a class="bk_pop" href="#bethlem.REF.j_bsis.1999.649">J&#x000f6;bsis et al 1999</a>].</div></li></ul><p><b>Ullrich CMD</b></p><ul><li class="half_rhythm"><div>Children require active physiotherapy management as soon as the diagnosis is established to promote mobility and independence. Early mobilization in standing frames is important to achieve upright posture and protect against the development of scoliosis and other contractures.</div></li><li class="half_rhythm"><div>Contractures tend to be aggressive and may require surgery.</div></li><li class="half_rhythm"><div>Feeding difficulties may manifest as failure to thrive or excessive time taken to finish eating a meal. Consultation with a nutrition specialist may be required to boost calorie intake; for serious problems, feeding by gastrostomy may be the best solution to promote a normal weight gain.</div></li><li class="half_rhythm"><div>Respiratory support with nocturnal ventilation usually becomes necessary in the first or second decade and can be effective in reducing symptoms, promoting quality of life, and allowing normal schooling [<a class="bk_pop" href="#bethlem.REF.wallgrenpettersson.2004.56">Wallgren-Pettersson et al 2004</a>].</div></li><li class="half_rhythm"><div>Scoliosis frequently develops in the first or second decade and requires active management including surgery.</div></li></ul></div><div id="bethlem.Prevention_of_Secondary_Complica"><h3>Prevention of Secondary Complications</h3><p>Prophylaxis of chest infections with vaccination and physiotherapy as well as early and aggressive use of antibiotics may prevent further respiratory problems in both disorders.</p></div><div id="bethlem.Surveillance"><h3>Surveillance</h3><p><b>Bethlem myopathy</b></p><ul><li class="half_rhythm"><div>Clinical assessment of muscle weakness, joint contractures, and mobility to inform physiotherapeutic advice regarding stretches/splints and mobility aids</div></li><li class="half_rhythm"><div>Assessments of respiratory function to detect asymptomatic decline. (Assess clinically by seeking history of clinical symptoms of nocturnal hypoventilation such as early-morning nausea and headaches, daytime somnolence; inquire about frequency and severity of chest infections; if any concerns, perform spirometry and nocturnal pulse oximetry.)</div></li></ul><p>Assessments should be repeated regularly, possibly annually, depending on the clinical status of the individual.</p><p><b>Ullrich CMD</b></p><ul><li class="half_rhythm"><div>Clinical assessment of muscle weakness, scoliosis, joint contractures, and mobility to inform physiotherapeutic advice regarding stretches/splints and mobility aids</div></li><li class="half_rhythm"><div>Once scoliosis is evident, regular orthopedic follow up</div></li><li class="half_rhythm"><div>Assessments of respiratory function to detect asymptomatic decline. (Assess clinically by seeking history of clinical symptoms of nocturnal hypoventilation such as early-morning nausea and headaches, daytime somnolence; inquire about frequency and severity of chest infections; if any concerns, perform spirometry and nocturnal pulse oximetry.)</div></li><li class="half_rhythm"><div>Clinical assessment of nutritional status</div></li></ul><p>Assessments should be repeated regularly, possibly biannually, depending on the clinical status of the individual.</p></div><div id="bethlem.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#bethlem.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="bethlem.Pregnancy_Management"><h3>Pregnancy Management</h3><p>For a pregnant woman with a collagen VI-related disorder, no specific pregnancy management issues exist; however, prenatal physiotherapy may be indicated.</p></div><div id="bethlem.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="bethlem.Genetic_Counseling"><h2 id="_bethlem_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="bethlem.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The collagen type VI- related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><ul><li class="half_rhythm"><div>The Bethlem myopathy <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is usually inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, although <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance has been reported [<a class="bk_pop" href="#bethlem.REF.foley.2009.813">Foley et al 2009</a>, <a class="bk_pop" href="#bethlem.REF.gualandi.2009.1883">Gualandi et al 2009</a>].</div></li><li class="half_rhythm"><div>The Ullrich <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (CMD) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is usually inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner, although <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance has been reported in four individuals with <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants [<a class="bk_pop" href="#bethlem.REF.pan.2003.355">Pan et al 2003</a>, <a class="bk_pop" href="#bethlem.REF.baker.2005.279">Baker et al 2005</a>], and suspected in three others [<a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>].</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> limb-girdle muscular dystrophy and myosclerosis myopathy phenotypes are inherited in an autosomal dominant and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner, respectively.</div></li><li class="half_rhythm"><div>Most individuals with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> collagen type VI disorder (i.e., who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>COL6A1</i>, <i>COL6A2</i>, or <i>COL6A3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) are symptomatic.</div></li><li class="half_rhythm"><div>Parents of individuals with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> collagen type VI disorder (i.e., who are usually <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>COL6A1</i>, <i>COL6A2</i>, or <i>COL6A3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) do not appear to manifest any related symptoms.</div></li><li class="half_rhythm"><div>Individuals with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> collagen type VI disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be distinguished clinically from those with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> collagen type VI disorder.</div></li></ul></div><div id="bethlem.Autosomal_Dominant_Inheritance"><h3>Autosomal Dominant Inheritance &#x02013; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals diagnosed with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> collagen type VI-related disorder may have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> collagen type VI-related disorder may have the disorder as the result of a new <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#bethlem.REF.pan.2003.355">Pan et al 2003</a>]. The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant is thought to be greater than 50% [<a class="bk_pop" href="#bethlem.REF.allamand.2011.30">Allamand et al 2011</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include clinical assessment by a clinician specializing in muscle disorders and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, if the variant has been identified in the proband.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband and/or is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the chance that a sib will inherit the variant is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low, but greater than that of the general population because of possible reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in the parent and/or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> collagen VI-related disorder has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband and/or is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="bethlem.Autosomal_Recessive_Inheritance"><h3>Autosomal Recessive Inheritance</h3><div id="bethlem.Risk_to_Family_Members"><h4>Risk to Family Members</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of a child with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> collagen type VI-related disorder are usually heterozygotes and, therefore, carry one mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are usually asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being neither affected nor a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the chance of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> collagen type VI-related disorder are obligate heterozygotes for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are themselves unaffected unless they inherit a second pathogenic variant from their other parent.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="bethlem.Carrier_Heterozygote_Detection"><h4>Carrier (Heterozygote) Detection</h4><p>Carrier testing for family members at risk of being carriers of an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> collagen type VI-related disorder is possible if the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="bethlem.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bethlem.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="bethlem.Resources"><h2 id="_bethlem_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Cure CMD</b></div><div>19401 South Vermont Avenue</div><div>Suite J100</div><div>Torrance CA 90502</div><div><b>Phone:</b> 323-250-2399</div><div><b>Fax:</b> 310-684-2023</div><div><b>Email:</b> info@curecmd.org</div><div><a href="http://www.curecmd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.curecmd.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>Congenital Muscle Disease International Registry (CMDIR)</b></div><div><i>The CMDIR is a patient self-report registry with the goal to register the global <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscle disease population including persons with congenital myopathy, congenital muscular dystrophy, and congenital myasthenic syndrome. The CMDIR registers <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of all ages with symptoms from birth through late onset (limb-girdle). Registrants will receive educational information and connections to others in the CMD community, and will be contacted about potential participation in clinical trials for their CMD subtype.</i></div><div>19401 South Vermont Avenue</div><div>Suite J100</div><div>Torrance CA 90502</div><div><b>Phone:</b> 323-250-2399</div><div><b>Fax:</b> 310-684-2023</div><div><b>Email:</b> counselor@cmdir.org; sarah.foye@cmdir.org</div><div><a href="http://www.cmdir.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cmdir.org</a></div></li></ul></div><div id="bethlem.Molecular_Genetics"><h2 id="_bethlem_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="bethlem.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Collagen Type VI-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1503/table/bethlem.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bethlem.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_bethlem.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_bethlem.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_bethlem.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_bethlem.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_bethlem.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_bethlem.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_bethlem.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1291" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL6A1</i></a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1291" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">21q22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P12109" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-1(VI) chain</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/COL6A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A1 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL6A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A1</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL6A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A1</a></td></tr><tr><td headers="hd_b_bethlem.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1292" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL6A2</i></a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1292" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">21q22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P12110" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-2(VI) chain</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/COL6A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A2 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL6A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A2</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL6A2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A2</a></td></tr><tr><td headers="hd_b_bethlem.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1293" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL6A3</i></a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1293" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q37<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P12111" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-3(VI) chain</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/COL6A3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A3 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL6A3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A3</a></td><td headers="hd_b_bethlem.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL6A3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL6A3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="bethlem.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="bethlem.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Collagen Type VI-Related Disorders (<a href="/omim/120220,120240,120250,158810,254090" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1503/table/bethlem.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bethlem.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120220" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120220</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE VI, ALPHA-1; COL6A1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120240" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120240</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE VI, ALPHA-2; COL6A2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120250" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120250</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE VI, ALPHA-3; COL6A3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/158810" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">158810</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BETHLEM MYOPATHY 1; BTHLM1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/254090" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">254090</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1</td></tr></tbody></table></div></div><div id="bethlem.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Collagen VI comprises the three peptide chains &#x003b1;1(VI), &#x003b1;2(VI) (both 140 kd in size), and &#x003b1;3(VI) (260-300 kd in size) [<a class="bk_pop" href="#bethlem.REF.engvall.1986.703">Engvall et al 1986</a>]. The &#x003b1;1(VI) and &#x003b1;2(VI) chains are encoded by the genes <i>COL6A1</i> and <i>COL6A2</i>, respectively, which are situated head-to-tail on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 21q22.3 [<a class="bk_pop" href="#bethlem.REF.heiskanen.1995.801">Heiskanen et al 1995</a>] and separated by 150 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. <i>COL6A3</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the &#x003b1;3(VI) chain, is on chromosome 2q37 [<a class="bk_pop" href="#bethlem.REF.weil.1988.435">Weil et al 1988</a>].</p><p>All three chains contain a central short triple helical <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of 335-336 amino acids with repeating Gly-Xaa-Yaa sequences flanked by large N- and C- terminal globular domains consisting of motifs of approximately 200 amino acids each homologous to von Willebrand factor (vWF) type A domains [<a class="bk_pop" href="#bethlem.REF.chu.1990.55">Chu et al 1990</a>].</p><p><b>Gene structure</b></p><ul><li class="half_rhythm"><div><b><i>COL6A1</i></b> comprises 37 exons (35 of which are coding) and produces a single transcript encoding a protein of 1,021 amino acids with two C-terminal and one N-terminal vWF type A-like domains.</div></li><li class="half_rhythm"><div><b><i>COL6A2</i></b> comprises 30 exons (29 of which are coding) and has been shown to produce multiple alternatively spliced mRNAs that differ in the 5'-untranslated region as well as in the 3'-coding and noncoding sequences. It produces at least three &#x003b1;2(VI) protein variants (828-1,019 amino acids) with distinct carboxyl termini, which similarly contain two C-terminal and one N-terminal vWF type A-like <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#bethlem.REF.saitta.1990.6473">Saitta et al 1990</a>].</div></li><li class="half_rhythm"><div><b><i>COL6A3</i></b> comprises 44 exons (43 of which are coding) and encodes the &#x003b1;3(VI) chain, which can vary in size between 2,970 and 3,176 amino acids. The &#x003b1;3(VI) chain contains two C-terminal vWF type A-like domains, subdomains similar to type III fibronectin repeats and Kunitz protease inhibitors as well as six to ten N-terminal vWF type A-like domains, thus contributing most of the amino-terminal globular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the collagen VI heterotrimer. Various N-terminal exons of <i>COL6A3</i> are subject to alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> and four variant transcripts encoding proteins with variably sized N-terminal globular domains have been characterized [<a class="bk_pop" href="#bethlem.REF.stokes.1991.8626">Stokes et al 1991</a>, <a class="bk_pop" href="#bethlem.REF.dziadek.2002.227">Dziadek et al 2002</a>].</div></li></ul><p>For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1503/#bethlem.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants</b></p><ul><li class="half_rhythm"><div>Single amino acid substitutions disrupting the Gly-Xaa-Yaa motif of the highly conserved triple helical <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of any of the three <i>COL6A</i> genes [<a class="bk_pop" href="#bethlem.REF.j_bsis.1996.113">J&#x000f6;bsis et al 1996</a>, <a class="bk_pop" href="#bethlem.REF.pepe.1999a.264">Pepe et al 1999a</a>, <a class="bk_pop" href="#bethlem.REF.scacheri.2002.593">Scacheri et al 2002</a>, <a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>, <a class="bk_pop" href="#bethlem.REF.lucioli.2005.1931">Lucioli et al 2005</a>] constitute the most frequent pathogenic mechanism at 28% of the total pathogenic variants in <i>COL6A1</i>, <i>COL6A2</i>, and <i>COL6A3</i>.</div></li><li class="half_rhythm"><div>Pathogenic variants that introduce premature termination codons (splice sites and out-of-frame deletions/insertions) form the second most frequent group at 28%.</div></li><li class="half_rhythm"><div>Splice site variants that cause <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> skipping occur at around the same frequency [<a class="bk_pop" href="#bethlem.REF.lamand_.1999.21817">Lamand&#x000e9; et al 1999</a>, <a class="bk_pop" href="#bethlem.REF.pepe.1999b.802">Pepe et al 1999b</a>, <a class="bk_pop" href="#bethlem.REF.pan.2003.355">Pan et al 2003</a>, <a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>, <a class="bk_pop" href="#bethlem.REF.lucioli.2005.1931">Lucioli et al 2005</a>], with 27% of the total.</div></li><li class="half_rhythm"><div>Other <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants causing small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions or insertions in regions that encode domains flanking the triple helical <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> make up 8% of the total of pathogenic variants in <i>COL6A1</i>, <i>COL6A2</i>, and <i>COL6A</i>, with large <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> deletions appearing to be rare and occurring at a frequency of around 2% [<a class="bk_pop" href="#bethlem.REF.vanegas.2002.513">Vanegas et al 2002</a>, <a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>, <a class="bk_pop" href="#bethlem.REF.lucioli.2005.1931">Lucioli et al 2005</a>].</div></li></ul><p>Given the high number of variants that result in benign amino acid changes described for the three genes encoding the three collagen VI peptide chains, it is difficult to be sure about the pathogenicity of <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants other than glycine substitutions within the triple helical <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Extracellular matrix molecules are critical for skeletal muscle stability, regeneration, and muscle cell matrix adhesion [<a class="bk_pop" href="#bethlem.REF.helblingleclerc.1995.216">Helbling-Leclerc et al 1995</a>, <a class="bk_pop" href="#bethlem.REF.sewry.1999.519">Sewry &#x00026; Muntoni 1999</a>, <a class="bk_pop" href="#bethlem.REF.emery.2002.687">Emery 2002</a>]. Collagen VI is a ubiquitous extracellular matrix protein [<a class="bk_pop" href="#bethlem.REF.von_der_mark.1984.493">von der Mark et al 1984</a>] that forms a microfibrillar network in close association with the basement membrane around muscle cells and interacts with several other matrix constituents [<a class="bk_pop" href="#bethlem.REF.burg.1996.26110">Burg et al 1996</a>, <a class="bk_pop" href="#bethlem.REF.kuo.1997.26522">Kuo et al 1997</a>, <a class="bk_pop" href="#bethlem.REF.wiberg.2003.37698">Wiberg et al 2003</a>].</p><p>The assembly of collagen VI is a complex multistep process. Association of the three genetically distinct subunits &#x003b1;1(VI), &#x003b1;2(VI), and &#x003b1;3(VI) to form a triple helical monomer is followed by staggered assembly into disulfide-bonded antiparallel dimers, which then align to form tetramers, also stabilized by disulfide bonds. Outside of the cell, tetramers, the secreted form of collagen VI, associate end to end to form the characteristic beaded microfibrils [<a class="bk_pop" href="#bethlem.REF.furthmayr.1983.303">Furthmayr et al 1983</a>, <a class="bk_pop" href="#bethlem.REF.engvall.1986.703">Engvall et al 1986</a>, <a class="bk_pop" href="#bethlem.REF.lamand_.1998.7423">Lamand&#x000e9; et al 1998</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b></p><ul><li class="half_rhythm"><div><b>Autosomal dominant collagen type VI-related disorders.</b> Heterozygous single amino acid substitutions disrupting the Gly-Xaa-Yaa motif of the highly conserved triple helical <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of any of the three <i>COL6A</i> genes [<a class="bk_pop" href="#bethlem.REF.j_bsis.1996.113">J&#x000f6;bsis et al 1996</a>, <a class="bk_pop" href="#bethlem.REF.pepe.1999a.264">Pepe et al 1999a</a>, <a class="bk_pop" href="#bethlem.REF.scacheri.2002.593">Scacheri et al 2002</a>, <a class="bk_pop" href="#bethlem.REF.lampe.2005.108">Lampe et al 2005</a>, <a class="bk_pop" href="#bethlem.REF.lucioli.2005.1931">Lucioli et al 2005</a>], depending on their location, appear to either interfere with intracellular chain assembly or, following successful secretion, cause kinking of the tetramers, thus affecting extracellular microfibril formation [<a class="bk_pop" href="#bethlem.REF.lamand_.2002.1949">Lamand&#x000e9; et al 2002</a>]. Functional <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> via a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect has also been reported as the pathogenic mechanism for some <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants [<a class="bk_pop" href="#bethlem.REF.lamand_.1999.21817">Lamand&#x000e9; et al 1999</a>]. Heterozygous splice site variants (associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disease) leading to <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions as well as in-frame <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> deletions preserve a unique cysteine important for dimer formation, allowing secretion of abnormal tetramers with a consequent dominant-negative effect on microfibrillar assembly [<a class="bk_pop" href="#bethlem.REF.pan.2003.355">Pan et al 2003</a>, <a class="bk_pop" href="#bethlem.REF.baker.2005.279">Baker et al 2005</a>].</div></li><li class="half_rhythm"><div><b>Autosomal recessive collagen type VI-related disorders.</b> Most variants associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disease reported to date are protein-truncating <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants. Some have been shown to result in absence of collagen VI because of nonsense-mediated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> decay [<a class="bk_pop" href="#bethlem.REF.zhang.2002.43557">Zhang et al 2002</a>].</div></li></ul></div></div><div id="bethlem.References"><h2 id="_bethlem_References_">References</h2><div id="bethlem.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.allamand.2011.30">Allamand V, Bri&#x000f1;as L, Richard P, Stojkovic T, Quijano-Roy S, Bonne G. ColVI myopathies: where do we stand, where do we go? <span><span class="ref-journal">Skelet Muscle. </span>2011;<span class="ref-vol">1</span>:30.</span> [<a href="/pmc/articles/PMC3189202/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3189202</span></a>] [<a href="/pubmed/21943391" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21943391</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.baker.2005.279">Baker NL, Morgelin M, Peat R, Goemans N, North KN, Bateman JF, Lamande SR. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:279–93.</span> [<a href="/pubmed/15563506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15563506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.bethlem.1976.91">Bethlem J, Wijngaarden GK. Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees. <span><span class="ref-journal">Brain. </span>1976;<span class="ref-vol">99</span>:91–100.</span> [<a href="/pubmed/963533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 963533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.bovolenta.2010.44">Bovolenta M, Neri M, Martoni E, Urciuolo A, Sabatelli P, Fabris M, Grumati P, Mercuri E, Bertini E, Merlini L, Bonaldo P, Ferlini A, Gualandi F. Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies. <span><span class="ref-journal">BMC Med Genet. </span>2010;<span class="ref-vol">11</span>:44.</span> [<a href="/pmc/articles/PMC2850895/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2850895</span></a>] [<a href="/pubmed/20302629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20302629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.bri_as.2010.511">Bri&#x000f1;as L, Richard P, Quijano-Roy S, Gartioux C, Ledeuil C, Lac&#x000e8;ne E, Makri S, Ferreiro A, Maugenre S, Topaloglu H, Haliloglu G, P&#x000e9;nisson-Besnier I, Jeannet PY, Merlini L, Navarro C, Toutain A, Chaigne D, Desguerre I, de Die-Smulders C, Dunand M, Echenne B, Eymard B, Kuntzer T, Maincent K, Mayer M, Plessis G, Rivier F, Roelens F, Stojkovic T, Taratuto AL, Lubieniecki F, Monges S, Tranchant C, Viollet L, Romero NB, Estournet B, Guicheney P, Allamand V. Early onset collagen VI myopathies: Genetic and clinical correlations. <span><span class="ref-journal">Ann Neurol. </span>2010;<span class="ref-vol">68</span>:511–20.</span> [<a href="/pubmed/20976770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20976770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.burg.1996.26110">Burg MA, Tillet E, Timpl R, Stallcup WB. Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. <span><span class="ref-journal">J Biol Chem. </span>1996;<span class="ref-vol">271</span>:26110–6.</span> [<a href="/pubmed/8824254" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8824254</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.camacho_vanegas.2001.7516">Camacho Vanegas O, Bertini E, Zhang RZ, Petrini S, Minosse C, Sabatelli P, Giusti B, Chu ML, Pepe G. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2001;<span class="ref-vol">98</span>:7516–21.</span> [<a href="/pmc/articles/PMC34700/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC34700</span></a>] [<a href="/pubmed/11381124" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11381124</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.chu.1990.55">Chu ML, Pan TC, Conway D, Saitta B, Stokes D, Kuo HJ, Glanville RW, Timpl R, Mann K, Deutzmann R. The structure of type VI collagen. <span><span class="ref-journal">Ann N Y Acad Sci. </span>1990;<span class="ref-vol">580</span>:55–63.</span> [<a href="/pubmed/2337306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2337306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.de_visser.1992.591">de Visser M, de Voogt WG, la Riviere GV. The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy. <span><span class="ref-journal">Muscle Nerve. </span>1992;<span class="ref-vol">15</span>:591–6.</span> [<a href="/pubmed/1584251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1584251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.demir.2002.1446">Demir E, Sabatelli P, Allamand V, Ferreiro A, Moghadaszadeh B, Makrelouf M, Topaloglu H, Echenne B, Merlini L, Guicheney P. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:1446–58.</span> [<a href="/pmc/articles/PMC419991/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC419991</span></a>] [<a href="/pubmed/11992252" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11992252</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.dziadek.2002.227">Dziadek M, Kazenwadel JS, Hendrey JA, Pan TC, Zhang RZ, Chu ML. Alternative splicing of transcripts for the alpha 3 chain of mouse collagen VI: identification of an abundant isoform lacking domains N7-N10 in mouse and human. <span><span class="ref-journal">Matrix Biol. </span>2002;<span class="ref-vol">21</span>:227–41.</span> [<a href="/pubmed/12009329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12009329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.emery.2002.687">Emery AE. The muscular dystrophies. <span><span class="ref-journal">Lancet. </span>2002;<span class="ref-vol">359</span>:687–95.</span> [<a href="/pubmed/11879882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11879882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.engvall.1986.703">Engvall E, Hessle H, Klier G. Molecular assembly, secretion, and matrix deposition of type VI collagen. <span><span class="ref-journal">J Cell Biol. </span>1986;<span class="ref-vol">102</span>:703–10.</span> [<a href="/pmc/articles/PMC2114116/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2114116</span></a>] [<a href="/pubmed/3456350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3456350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.foley.2009.813">Foley AR, Hu Y, Zou Y, Columbus A, Shoffner J, Dunn DM, Weiss RB, B&#x000f6;nnemann CG. Autosomal recessive inheritance of classic Bethlem myopathy. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:813–7.</span> [<a href="/pmc/articles/PMC2787906/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2787906</span></a>] [<a href="/pubmed/19884007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19884007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.foley.2011.206">Foley AR, Hu Y, Zou Y, Yang M, Medne L, Leach M, Conlin LK, Spinner N, Shaikh TH, Falk M, Neumeyer AM, Bliss L, Tseng BS, Winder TL, B&#x000f6;nnemann CG. Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy. <span><span class="ref-journal">Ann Neurol. </span>2011;<span class="ref-vol">69</span>:206–11.</span> [<a href="/pmc/articles/PMC5154621/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5154621</span></a>] [<a href="/pubmed/21280092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21280092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.furthmayr.1983.303">Furthmayr H, Wiedemann H, Timpl R, Odermatt E, Engel J. Electron-microscopical approach to a structural model of intima collagen. <span><span class="ref-journal">Biochem J. </span>1983;<span class="ref-vol">211</span>:303–11.</span> [<a href="/pmc/articles/PMC1154360/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1154360</span></a>] [<a href="/pubmed/6307276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6307276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.furukawa.1977.426">Furukawa T, Toyokura Y. Congenital, hypotonic-sclerotic muscular dystrophy. <span><span class="ref-journal">J Med Genet. </span>1977;<span class="ref-vol">14</span>:426–9.</span> [<a href="/pmc/articles/PMC1013639/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1013639</span></a>] [<a href="/pubmed/604494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 604494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.giusti.2005.400">Giusti B, Lucarini L, Pietroni V, Lucioli S, Bandinelli B, Sabatelli P, Squarzoni S, Petrini S, Gartioux C, Talim B, Roelens F, Merlini L, Topaloglu H, Bertini E, Guicheney P, Pepe G. Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">58</span>:400–10.</span> [<a href="/pubmed/16130093" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16130093</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.gualandi.2009.1883">Gualandi F, Urciuolo A, Martoni E, Sabatelli P, Squarzoni S, Bovolenta M, Messina S, Mercuri E, Franchella A, Ferlini A, Bonaldo P, Merlini L. Autosomal recessive Bethlem myopathy. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:1883–91.</span> [<a href="/pubmed/19949035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19949035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.haq.1999.174">Haq RU, Speer MC, Chu ML, Tandan R. Respiratory muscle involvement in Bethlem myopathy. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">52</span>:174–6.</span> [<a href="/pubmed/9921869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9921869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.heiskanen.1995.801">Heiskanen M, Saitta B, Palotie A, Chu ML. Head to tail organization of the human COL6A1 and COL6A2 genes by fiber-FISH. <span><span class="ref-journal">Genomics. </span>1995;<span class="ref-vol">29</span>:801–3.</span> [<a href="/pubmed/8575781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8575781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.helblingleclerc.1995.216">Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tome FM, Schwartz K, Fardeau M, Tryggvason K, et al.  Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">11</span>:216–8.</span> [<a href="/pubmed/7550355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7550355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.hicks.2008.1192">Hicks D, Lampe AK, Barresi R, Charlton R, Fiorillo C, Bonnemann CG, Hudson J, Sutton R, Lochm&#x000fc;ller H, Straub V, Bushby K. A refined diagnostic algorithm for Bethlem myopathy. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">70</span>:1192–9.</span> [<a href="/pubmed/18378883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18378883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.higuchi.2001.261">Higuchi I, Shiraishi T, Hashiguchi T, Suehara M, Niiyama T, Nakagawa M, Arimura K, Maruyama I, Osame M. Frameshift mutation in the collagen VI gene causes Ullrich's disease. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">50</span>:261–5.</span> [<a href="/pubmed/11506412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11506412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.higuchi.2003.310">Higuchi I, Horikiri T, Niiyama T, Suehara M, Shiraishi T, Hu J, Uchida Y, Saito A, Nakagawa M, Arimura K, Osame M. Pathological characteristics of skeletal muscle in Ullrich's disease with collagen VI deficiency. <span><span class="ref-journal">Neuromuscul Disord. </span>2003;<span class="ref-vol">13</span>:310–6.</span> [<a href="/pubmed/12868500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12868500</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.ishikawa.2002.920">Ishikawa H, Sugie K, Murayama K, Ito M, Minami N, Nishino I, Nonaka I. Ullrich disease: collagen VI deficiency: EM suggests a new basis for muscular weakness. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:920–3.</span> [<a href="/pubmed/12297580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12297580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.ishikawa.2004.620">Ishikawa H, Sugie K, Murayama K, Awaya A, Suzuki Y, Noguchi S, Hayashi YK, Nonaka I, Nishino I. Ullrich disease due to deficiency of collagen VI in the sarcolemma. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:620–3.</span> [<a href="/pubmed/14981181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14981181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.jimenezmallebrera.2006.571">Jimenez-Mallebrera C, Maioli MA, Kim J, Brown SC, Feng L, Lampe AK, Bushby K, Hicks D, Flanigan KM, Bonnemann C, Sewry CA, Muntoni F. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations. <span><span class="ref-journal">Neuromuscul Disord. </span>2006;<span class="ref-vol">16</span>:571–82.</span> [<a href="/pubmed/16935502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16935502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.j_bsis.1996.113">J&#x000f6;bsis GJ, Keizers H, Vreijling JP, de Visser M, Speer MC, Wolterman RA, Baas F, Bolhuis PA. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">14</span>:113–5.</span> [<a href="/pubmed/8782832" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8782832</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.j_bsis.1999.649">J&#x000f6;bsis GJ, Boers JM, Barth PG, de Visser M. Bethlem myopathy: a slowly progressive congenital muscular dystrophy with contractures. <span><span class="ref-journal">Brain. </span>1999;<span class="ref-vol">122</span>:649–55.</span> [<a href="/pubmed/10219778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10219778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.kuo.1997.26522">Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. <span><span class="ref-journal">J Biol Chem. </span>1997;<span class="ref-vol">272</span>:26522–9.</span> [<a href="/pubmed/9334230" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9334230</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.lamand_.1999.21817">Lamand&#x000e9; SR, Shields KA, Kornberg AJ, Shield LK, Bateman JF. Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:21817–22.</span> [<a href="/pubmed/10419498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10419498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.lamand_.2002.1949">Lamand&#x000e9; SR, Morgelin M, Selan C, J&#x000f6;bsis GJ, Baas F, Bateman JF. Kinked collagen VI tetramers and reduced microfibril formation as a result of Bethlem myopathy and introduced triple helical glycine mutations. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:1949–56.</span> [<a href="/pubmed/11707460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11707460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.lamand_.1998.7423">Lamand&#x000e9; SR, Sigalas E, Pan TC, Chu ML, Dziadek M, Timpl R, Bateman JF. The role of the alpha3(VI) chain in collagen VI assembly. Expression of an alpha3(VI) chain lacking N-terminal modules N10-N7 restores collagen VI assembly, secretion, and matrix deposition in an alpha3(VI)-deficient cell line. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>:7423–30.</span> [<a href="/pubmed/9516440" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9516440</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.lampe.2005.108">Lampe AK, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Laval SH, Marie SK, Chu ML, Swoboda K, Muntoni F, Bonnemann CG, Flanigan KM, Bushby KM, Weiss RB. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:108–20.</span> [<a href="/pmc/articles/PMC1736000/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736000</span></a>] [<a href="/pubmed/15689448" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15689448</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.lucioli.2005.1931">Lucioli S, Giusti B, Mercuri E, Vanegas OC, Lucarini L, Pietroni V, Urtizberea A, Ben Yaou R, de Visser M, van der Kooi AJ, Bonnemann C, Iannaccone ST, Merlini L, Bushby K, Muntoni F, Bertini E, Chu ML, Pepe G. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1931–7.</span> [<a href="/pubmed/15955946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15955946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.mercuri.2005.303">Mercuri E, Lampe A, Allsop J, Knight R, Pane M, Kinali M, Bonnemann C, Flanigan K, Lapini I, Bushby K, Pepe G, Muntoni F. Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. <span><span class="ref-journal">Neuromuscul Disord. </span>2005;<span class="ref-vol">15</span>:303–10.</span> [<a href="/pubmed/15792870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15792870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.merlini.2008.1245">Merlini L, Martoni E, Grumati P, Sabatelli P, Squarzoni S, Urciuolo A, Ferlini A, Gualandi F, Bonaldo P. Autosomal recessive myosclerosis myopathy is a collagen VI disorder. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:1245–53.</span> [<a href="/pubmed/18852439" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18852439</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.mohire.1988.573">Mohire MD, Tandan R, Fries TJ, Little BW, Pendlebury WW, Bradley WG. Early-onset benign autosomal dominant limb-girdle myopathy with contractures (Bethlem myopathy). <span><span class="ref-journal">Neurology. </span>1988;<span class="ref-vol">38</span>:573–80.</span> [<a href="/pubmed/3352914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3352914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.muntoni.2002.889">Muntoni F, Bertini E, Bonnemann C, Brockington M, Brown S, Bushby K, Fiszman M, Korner C, Mercuri E, Merlini L, Hewitt J, Quijano-Roy S, Romero N, Squarzoni S, Sewry CA, Straub V, Topaloglu H, Haliloglu G, Voit T, Wewer U, Guicheney P. 98th ENMC International Workshop on Congenital Muscular Dystrophy (CMD), 7th Workshop of the International Consortium on CMD, 2nd Workshop of the MYO CLUSTER project GENRE. 26-28th October, 2001, Naarden, The Netherlands. <span><span class="ref-journal">Neuromuscul Disord. </span>2002;<span class="ref-vol">12</span>:889–96.</span> [<a href="/pubmed/12398845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12398845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.norwood.2009.3175">Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. <span><span class="ref-journal">Brain. </span>2009;<span class="ref-vol">132</span>:3175–86.</span> [<a href="/pmc/articles/PMC4038491/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4038491</span></a>] [<a href="/pubmed/19767415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19767415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.pan.2003.355">Pan TC, Zhang RZ, Sudano DG, Marie SK, Bonnemann CG, Chu ML. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">73</span>:355–69.</span> [<a href="/pmc/articles/PMC1180372/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180372</span></a>] [<a href="/pubmed/12840783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12840783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.peat.2007.547">Peat RA, Baker NL, Jones KJ, North KN, Lamand&#x000e9; SR. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families. <span><span class="ref-journal">Neuromuscul Disord. </span>2007;<span class="ref-vol">17</span>:547–57.</span> [<a href="/pubmed/17537636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17537636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.pepe.2002.984">Pepe G, Bertini E, Bonaldo P, Bushby K, Giusti B, de Visser M, Guicheney P, Lattanzi G, Merlini L, Muntoni F, Nishino I, Nonaka I, Yaou RB, Sabatelli P, Sewry C, Topaloglu H, van der Kooi A. Bethlem myopathy (BETHLEM) and Ullrich scleroatonic muscular dystrophy: 100th ENMC international workshop, 23-24 November 2001, Naarden, The Netherlands. <span><span class="ref-journal">Neuromuscul Disord. </span>2002;<span class="ref-vol">12</span>:984–93.</span> [<a href="/pubmed/12467756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12467756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.pepe.1999a.264">Pepe G, Bertini E, Giusti B, Brunelli T, Comeglio P, Saitta B, Merlini L, Chu ML, Federici G, Abbate R. A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy. A diagnostic approach in the mutations' screening of type VI collagen. <span><span class="ref-journal">Neuromuscul Disord. </span>1999a;<span class="ref-vol">9</span>:264–71.</span> [<a href="/pubmed/10399756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10399756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.pepe.1999b.802">Pepe G, Giusti B, Bertini E, Brunelli T, Saitta B, Comeglio P, Bolognese A, Merlini L, Federici G, Abbate R, Chu ML. A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathy. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1999b;<span class="ref-vol">258</span>:802–7.</span> [<a href="/pubmed/10329467" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10329467</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.pepe.2006.190">Pepe G, Lucarini L, Zhang RZ, Pan TC, Giusti B, Quijano-Roy S, Gartioux C, Bushby KM, Guicheney P, Chu ML. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">59</span>:190–5.</span> [<a href="/pubmed/16278855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16278855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.saitta.1990.6473">Saitta B, Stokes DG, Vissing H, Timpl R, Chu ML. Alternative splicing of the human alpha 2(VI) collagen gene generates multiple mRNA transcripts which predict three protein variants with distinct carboxyl termini. <span><span class="ref-journal">J Biol Chem. </span>1990;<span class="ref-vol">265</span>:6473–80.</span> [<a href="/pubmed/1690728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1690728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.scacheri.2002.593">Scacheri PC, Gillanders EM, Subramony SH, Vedanarayanan V, Crowe CA, Thakore N, Bingler M, Hoffman EP. Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">58</span>:593–602.</span> [<a href="/pubmed/11865138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11865138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.sewry.1999.519">Sewry CA, Muntoni F. Inherited disorders of the extracellular matrix. <span><span class="ref-journal">Curr Opin Neurol. </span>1999;<span class="ref-vol">12</span>:519–26.</span> [<a href="/pubmed/10590888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10590888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.stokes.1991.8626">Stokes DG, Saitta B, Timpl R, Chu ML. Human alpha 3(VI) collagen gene. Characterization of exons coding for the amino-terminal globular domain and alternative splicing in normal and tumor cells. <span><span class="ref-journal">J Biol Chem. </span>1991;<span class="ref-vol">266</span>:8626–33.</span> [<a href="/pubmed/2022673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2022673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.ullrich.1930.171">Ullrich O. Kongenitale, atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskulaeren Systems. <span><span class="ref-journal">Z Ges Neurol Psychiatr. </span>1930;<span class="ref-vol">126</span>:171–201.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.vanegas.2002.513">Vanegas OC, Zhang RZ, Sabatelli P, Lattanzi G, Bencivenga P, Giusti B, Columbaro M, Chu ML, Merlini L, Pepe G. Novel COL6A1 splicing mutation in a family affected by mild Bethlem myopathy. <span><span class="ref-journal">Muscle Nerve. </span>2002;<span class="ref-vol">25</span>:513–9.</span> [<a href="/pubmed/11932968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11932968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.voit.1998.65">Voit T. Congenital muscular dystrophies: 1997 update. <span><span class="ref-journal">Brain Dev. </span>1998;<span class="ref-vol">20</span>:65–74.</span> [<a href="/pubmed/9545174" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9545174</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.von_der_mark.1984.493">von der Mark H, Aumailley M, Wick G, Fleischmajer R, Timpl R. Immunochemistry, genuine size and tissue localization of collagen VI. <span><span class="ref-journal">Eur J Biochem. </span>1984;<span class="ref-vol">142</span>:493–502.</span> [<a href="/pubmed/6432530" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6432530</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.wallgrenpettersson.2004.56">Wallgren-Pettersson C, Bushby K, Mellies U, Simonds A. 117th ENMC workshop: ventilatory support in congenital neuromuscular disorders -- congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4-6 April 2003, Naarden, The Netherlands. <span><span class="ref-journal">Neuromuscul Disord. </span>2004;<span class="ref-vol">14</span>:56–69.</span> [<a href="/pubmed/14659414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14659414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.weil.1988.435">Weil D, Mattei MG, Passage E, N'Guyen VC, Pribula-Conway D, Mann K, Deutzmann R, Timpl R, Chu ML. Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. <span><span class="ref-journal">Am J Hum Genet. </span>1988;<span class="ref-vol">42</span>:435–45.</span> [<a href="/pmc/articles/PMC1715162/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1715162</span></a>] [<a href="/pubmed/3348212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3348212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.wiberg.2003.37698">Wiberg C, Klatt AR, Wagener R, Paulsson M, Bateman JF, Heinegard D, Morgelin M. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:37698–704.</span> [<a href="/pubmed/12840020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12840020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bethlem.REF.zhang.2002.43557">Zhang RZ, Sabatelli P, Pan TC, Squarzoni S, Mattioli E, Bertini E, Pepe G, Chu ML. Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:43557–64.</span> [<a href="/pubmed/12218063" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12218063</span></a>]</div></li></ul></div></div><div id="bethlem.Chapter_Notes"><h2 id="_bethlem_Chapter_Notes_">Chapter Notes</h2><div id="bethlem.Author_Notes"><h3>Author Notes</h3><p>Newcastle upon Tyne Hospitals: <a href="http://www.newcastle-hospitals.org.uk/services/northern-genetics_treatment-and-medication_bethlem-myopathy.aspx" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Information</a></p></div><div id="bethlem.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>9 August 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 April 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 June 2004 (me) Review posted live</div></li><li class="half_rhythm"><div>18 February 2004 (kf) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1503</span><span class="label">PMID: <a href="/pubmed/20301676" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301676</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ciss/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pai-1-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1503&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1503/?report=reader">PubReader</a></li><li><a href="/books/NBK1503/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1503" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1503" style="display:none" title="Cite this Page"><div class="bk_tt">Lampe AK, Flanigan KM, Bushby KM, et al. Collagen Type VI-Related Disorders. 2004 Jun 25 [Updated 2012 Aug 9]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1503/pdf/Bookshelf_NBK1503.pdf">PDF version of this page</a> (714K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#bethlem.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#bethlem.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#bethlem.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#bethlem.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#bethlem.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#bethlem.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#bethlem.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#bethlem.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#bethlem.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#bethlem.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#bethlem.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#bethlem.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1292[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL6A2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1293[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL6A3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1291[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL6A1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1465292" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1465292" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1465292" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1465292" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301468" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sparks SE, Quijano-Roy S, Harper A, Rutkowski A, Gordon E, Hoffman EP, Pegoraro E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301436" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Fiber-Type Disproportion</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Fiber-Type Disproportion<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">DeChene ET, Kang PB, Beggs AH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22068469" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Collagen VI-related muscle disorders].</a><span class="source">[Brain Nerve. 2011]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Collagen VI-related muscle disorders].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Higuchi I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain Nerve. 2011 Nov; 63(11):1169-78. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301490" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Calpainopathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Calpainopathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Angelini C, Fanin M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31471117" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study.</a><span class="source">[Neuromuscul Disord. 2019]</span><div class="brieflinkpop offscreen_noflow">Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Caria F, Cescon M, Gualandi F, Pichiecchio A, Rossi R, Rimessi P, Cotti Piccinelli S, Gallo Cassarino S, Gregorio I, Galvagni A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neuromuscul Disord. 2019 Sep; 29(9):657-663. Epub 2019 Jul 30.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301676" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301676" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8d5575f66d18aa201924">Collagen Type VI-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Collagen Type VI-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T03:59:01-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89E4B3DFC836810000000004EA026C&amp;ncbi_session=CE89E4B3DFC8D551_1258SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1503%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1503&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1503/&amp;ncbi_pagename=Collagen Type VI-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89E4B3DFC8D551_1258SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>